LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Completed · Phase 3 · Has a placebo group
Conditions studied: COVID-19
In brief
This study looks at the safety and effectiveness of LY3819253 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either LY3819253 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H1.
Key facts
- Study ID
- NCT05780268
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 314
- Starts
- 2020-08-05
- Expected to finish
- 2021-02-01
- Last updated by the study team
- 2023-12-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Community Regional Medical Center (Site 203-005), 2823 Fresno Street — Fresno, California, United States
- Keck Hospital of USC (Site 301-020), 1500 San Pablo Street — Los Angeles, California, United States
- UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St. — San Francisco, California, United States
- San Francisco VAMC (Site 074-002), 4150 Clement St. — San Francisco, California, United States
- UCSF Medical Center (Site 203-001), Moffitt-Long Hospital, 505 Parnassus Ave. — San Francisco, California, United States
- Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr. — Stanford, California, United States
- University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue — Aurora, Colorado, United States
- Denver Public Health (Site 017-004), 660 Bannock St., MC2600 (Infectious Disease Clinic) — Denver, Colorado, United States
- MedStar Georgetown University Hospital (Site 067-001), 3800 Reservoir Road NW — Washington D.C., District of Columbia, United States
- Miami VAMC (Site 074-003), 1201 NW 16 Street — Miami, Florida, United States
- Emory University (Site 301-008), The Emory Clinic, Bldg. A, Suite 2236, 1365 Clifton Rd., NE — Atlanta, Georgia, United States
- University of Kentucky Hospital (Site 210-004), 1000 South Limestone St. — Lexington, Kentucky, United States
- Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway — New Orleans, Louisiana, United States
- University of Maryland Medical Center (Site 301-019), 22 South Greene Street — Baltimore, Maryland, United States
- Massachusetts General Hospital (Site 202-002), 55 Fruit Street — Boston, Massachusetts, United States
- Baystate Medical Center (Site 201-001), 759 Chestnut Street — Springfield, Massachusetts, United States
- University of Michigan (Site 205-001), 1500 East Medical Center Drive — Ann Arbor, Michigan, United States
- Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd. — Detroit, Michigan, United States
- Hennepin Healthcare (Site 027-001), 701 Park Avenue — Minneapolis, Minnesota, United States
- University of Mississippi Medical Center (Site 202-005), 2500 North State Street — Jackson, Mississippi, United States
- Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive — Lebanon, New Hampshire, United States
- Montefiore Medical Center Weiler Hospital (Site 206-003), 1825 Eastchester Road — The Bronx, New York, United States
- Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street — The Bronx, New York, United States
- Duke University Hospital (Site 301-006), 2301 Erwin Road — Durham, North Carolina, United States
- Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.